GlaxoSmithKline has launched an internal investigation into potential violations of the Foreign Corrupt Practices Act for alleged bribery payments made to doctors in Iraq, nine months after becoming embroiled in a similar corruption probe for improper payments made in China.
Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,... More by Jaclyn Jaeger
We'll send a verification code to %EMAIL%.
